Early and late brain metastases in EGFR wild type and EGFR mutation positive non small cell lung cancer: Implications for survival.

被引:1
|
作者
Ho, Cheryl
Yamada, Andrew
Weber, Britta
Yuan, Ren
机构
[1] BC Canc Agcy, Vancouver, BC, Canada
[2] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e19065
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Radiographic patterns and survival of patients with early and late brain metastases in EGFR wild type and mutant non small cell lung cancer
    Ren Yuan
    Andrew Yamada
    Britta Weber
    Cheryl Ho
    Journal of Neuro-Oncology, 2016, 127 : 525 - 533
  • [2] Radiographic patterns and survival of patients with early and late brain metastases in EGFR wild type and mutant non small cell lung cancer
    Yuan, Ren
    Yamada, Andrew
    Weber, Britta
    Ho, Cheryl
    JOURNAL OF NEURO-ONCOLOGY, 2016, 127 (03) : 525 - 533
  • [3] Early versus Late Brain Metastases in Wild Type and Mutation Positive EGFR Patients
    Yuan, Ren
    Yamada, Andrew
    Weber, Britta
    Hoe, Cheryl
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S408 - S408
  • [4] The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
    Bai, Hao
    Xiong, Liwen
    Han, Baohui
    ONCOTARGETS AND THERAPY, 2017, 10 : 2335 - 2340
  • [5] EGFR mutation status on brain metastases from non-small cell lung cancer
    Hsu, Fred
    De Caluwe, Alex
    Anderson, David
    Nichol, Alan
    Toriumi, Ted
    Ho, Cheryl
    LUNG CANCER, 2016, 96 : 101 - 107
  • [6] The number of brain metastases predicts the survival of non-small cell lung cancer patients with EGFR mutation status
    Shao, Jun
    Li, Jingwei
    Song, Lujia
    He, Qiuyao
    Wu, Yuxuan
    Li, Linhui
    Liu, Dan
    Wang, Chengdi
    Li, Weimin
    CANCER REPORTS, 2022, 5 (09)
  • [7] Effect of EGFR amplification on survival of patients with EGFR mutation-positive non-small cell lung cancer.
    Xu, Yiquan
    Wang, Haibo
    Zheng, Xinlong
    Lin, Gen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] The impact of EGFR mutation status and single brain metastasis on the survival of non-small-cell lung cancer patients with brain metastases
    Fujita, Yuya
    Kinoshita, Manabu
    Ozaki, Tomohiko
    Takano, Koji
    Kunimasa, Kei
    Kimura, Madoka
    Inoue, Takako
    Tamiya, Motohiro
    Nishino, Kazumi
    Kumagai, Toru
    Kishima, Haruhiko
    Imamura, Fumio
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [9] EGFR mutation status and brain metastases in non-small cell lung cancer: an understudied problem
    Riess, Jonathan W.
    Nagpal, Seema
    TRANSLATIONAL CANCER RESEARCH, 2013, 2 (01) : 54 - 56
  • [10] Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
    Watanabe, Satomi
    Hayashi, Hidetoshi
    Nakagawa, Kazuhiko
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (11)